Revvity key statistics and ratios
In fiscal 2025, Revvity had return on equity of 3.2%, an operating margin of 12.5%, debt equal to 44.7% of equity and a current ratio of 1.68. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Jan 2010 | 2010Jan 2011 | 2011Jan 2012 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Jan 2016 | 2016Jan 2017 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Jan 2021 | 2021Jan 2022 | 2022Jan 2023 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 45.1% | 44.7% | 44.2% | 45.5% | 45.2% | 44.9% | 45.8% | 47.9% | 47.6% | 48.3% | 48.4% | 55.8% | 63.6% | 60.1% | — | — | — | — |
| Operating margin | 7.5% | 9.2% | 4.7% | 4.9% | 10.6% | 7.4% | 11.9% | 13.9% | 13.1% | 11.7% | 12.6% | 22.9% | 32.9% | 22.4% | 10.9% | 12.6% | 12.5% | 12.3% |
| Net margin | 5.3% | 22.9% | 0.4% | 3.3% | 7.8% | 7.1% | 10.1% | 11.1% | 13.0% | 8.6% | 7.9% | 19.2% | 24.6% | 17.2% | 25.2% | 9.8% | 8.4% | 8.2% |
| Free-cash-flow margin | 7.9% | 7.7% | 10.1% | 5.2% | 5.5% | 11.4% | 12.3% | 15.1% | 11.0% | 7.8% | 10.0% | 21.9% | 34.6% | 17.9% | 0.4% | 19.7% | 17.8% | 19.2% |
| Return on equity | 5.0% | 22.0% | 0.4% | 3.7% | 8.5% | 7.8% | 10.2% | 11.0% | 12.6% | 9.4% | 8.4% | 22.2% | 17.3% | 7.8% | 9.1% | 3.5% | 3.2% | 3.3% |
| Return on assets | 2.7% | 12.5% | 0.2% | 1.8% | 4.3% | 3.9% | 5.1% | 5.6% | 5.6% | 3.9% | 3.6% | 10.0% | 8.2% | 3.9% | 5.0% | 2.1% | 2.0% | 2.0% |
| Asset turnover | 0.51 | 0.54 | 0.54 | 0.55 | 0.55 | 0.55 | 0.51 | 0.50 | 0.44 | 0.46 | 0.46 | 0.52 | 0.33 | 0.23 | 0.20 | 0.21 | 0.23 | 0.24 |
| Current ratio | 1.78 | 2.11 | 1.48 | 1.67 | 1.73 | 1.79 | 1.84 | 1.97 | 1.26 | 1.60 | 1.80 | 1.36 | 2.01 | 2.13 | 2.07 | 3.60 | 1.68 | 1.80 |
| Debt to equity | 34.3% | 22.1% | 51.5% | 48.5% | 46.9% | 51.6% | 48.0% | 48.6% | 80.1% | 73.2% | 73.7% | 53.8% | 70.4% | 60.0% | 49.9% | 41.4% | 44.7% | 44.6% |
| Interest cover (operating income ÷ interest) | 7.2x | 9.9x | 3.7x | 2.3x | 4.6x | 4.5x | 6.6x | 7.1x | 6.7x | 4.8x | 5.7x | 17.4x | — | 7.1x | 3.0x | 3.6x | 3.9x | 3.8x |
| Effective tax rate | 26.7% | 16.3% | 98.2% | −29.2% | −6.5% | −5.1% | 9.6% | 11.6% | 47.1% | 7.8% | 4.0% | 21.2% | 26.1% | 21.3% | 1.9% | 10.5% | 10.6% | 9.0% |
| R&D as % of revenue | 5.8% | 5.6% | 6.0% | 6.2% | 6.1% | 4.8% | 5.3% | 5.9% | 6.2% | 7.0% | 6.6% | 3.9% | 5.2% | 6.7% | 7.9% | 7.1% | 7.6% | 7.4% |
| SG&A as % of revenue | 30.7% | 28.6% | 32.5% | 29.7% | 27.0% | 29.0% | 27.9% | 27.9% | 27.7% | 29.2% | 28.3% | 18.9% | 25.5% | 31.0% | 37.2% | 36.1% | 34.7% | 35.2% |
| Capital spending as % of revenue | 1.6% | 2.0% | 1.6% | 2.0% | 1.8% | 1.2% | 1.3% | 1.5% | 1.7% | 3.4% | 2.6% | 1.7% | 2.2% | 2.6% | 3.0% | 3.1% | 2.6% | 2.4% |
| Free cash flow ÷ net income | 150.1% | 33.4% | >999% | 156.9% | 71.5% | 161.3% | 121.9% | 136.1% | 85.2% | 91.5% | 126.2% | 113.8% | 140.5% | 104.4% | 1.4% | 200.3% | 211.2% | 234.9% |
| Dividends ÷ net income | 39.8% | 8.4% | 415.8% | 45.6% | 18.9% | 20.0% | 14.9% | 13.1% | 10.5% | 13.0% | 13.6% | 4.3% | 3.4% | 6.2% | 5.0% | 12.7% | 13.6% | 13.4% |
| Dividends and buybacks ÷ free cash flow | 38.4% | 81.0% | 73.0% | 31.0% | 132.9% | 38.2% | 41.7% | 57.3% | 13.9% | 40.6% | 13.0% | 4.6% | 8.0% | 19.5% | >999% | 74.6% | 167.6% | 90.9% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Apr 2026 | 2026 Q2Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 56.3% | — | 56.5% | 54.5% | 53.6% | — | 54.5% | 57.1% |
| Operating margin | 14.3% | 16.3% | 10.9% | 12.6% | 11.7% | 14.5% | 10.7% | 12.2% |
| Net margin | 13.8% | 13.0% | 6.4% | 7.5% | 6.7% | 12.7% | 5.7% | 7.1% |
| Free-cash-flow margin | 18.4% | 20.5% | 16.9% | 16.0% | 17.2% | 21.0% | 13.4% | 24.8% |
| Current ratio | 3.56 | 3.60 | 3.58 | 3.33 | 1.75 | 1.68 | 1.72 | 1.80 |
| Debt to equity | 40.2% | 41.1% | 41.5% | 42.5% | 43.6% | 44.4% | 44.7% | 44.3% |
| R&D as % of revenue | 7.2% | 6.7% | 8.1% | 7.4% | 7.3% | 7.5% | 8.1% | 6.7% |
| SG&A as % of revenue | 34.7% | 33.5% | 37.6% | 34.5% | 34.6% | 32.6% | 35.7% | 38.2% |
Financial health
- Short-term assets cover short-term liabilities $2.3bn of assets due within a year against $1.3bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $2.3bn short-term assets against $3.5bn of longer-dated liabilities.
- More cash than debt $1.0bn of cash against $3.2bn of debt.
- Debt below 40% of shareholders' equity Debt is 44% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 70% to 44% over five years.
- A year's operating cash flow covers at least 20% of debt $628m of operating cash flow against $3.2bn of debt.
- Operating profit covers interest at least five times over Operating income of $359m against $94m of interest.
Moat
Moderate moat
How hard Revvity's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 11 / 20
Cash operating profit has been a median 8.9% of total assets over 10 years.
- Pricing power 12 / 20
Gross margin has been a median 48.1%, moving by 6.3 percentage points (standard deviation) across 10 years.
- Durability 13 / 20
Operating margin has been a median 13.3%; its worst year was 10.2%.
- Cash conversion 17 / 20
Free cash flow was positive in 10 of 10 years, at a median 14.5% of revenue.
- Discipline 17 / 20
The diluted share count rose 0.5% over five years; stock-based pay has been a median 0.9% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Insulet Corporation statistics
- Globus Medical Inc statistics
- Quidelortho Corp statistics
- Enovis Corp statistics
- Teleflex Inc statistics
Head to head: PODD vs RVTYGMED vs RVTYQDEL vs RVTY
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies